Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Artimplant in connection with new share issue
Mandate

Vinge advises Artimplant in connection with new share issue

August 03, 2010

The board of directors of Artimplant AB (publ) has resolved to recommend that an extraordinary shareholders’ meeting adopt a resolution in respect of a rights issue to the existing members in order to provide the company with SEK 40,000,000 after issue costs.

Artimplant is listed on NASDAQ OMX Stockholm.

Vinge’s team primarily consisted of responsible partner Anders Strid and associates Anna Björk Larson and Emma Kero Ljungberg.

Related

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026

Vinge advises on the sale of Compab to Tången

 Vinge has advised the owners of Compab Energiteknik in connection with the sale of 80 per cent of the shares to Tången Industrikapital. Compab, which has a turnover of approximately SEK 100 million, sells, installs and services, amongst other things, steam and hot-water boilers as well as burners for the industrial sector.
October 26, 2026